Barnidipine, a Novel Calcium Antagonist for Once-Daily Treatment of Hypertension: A Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging Study

Author： Hart Wimpeter Holwerda Nicolas

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.11, Iss.5, 1997-11, pp. : 637-643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Speed of Onset and Efficacy of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine: A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study versus Zolmitriptan Tablet

By Charlesworth B.R.

CNS Drugs, Vol. 17, Iss. 9, 2003-01 ,pp. : 653-667

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension: A Double-Blind, Placebo-Controlled, Dose-Titration Study

By Guthrie R.

Clinical Drug Investigation, Vol. 15, Iss. 3, 1998-03 ,pp. : 217-227

Adis International

Access to resources Recommend Favorite

Calcium Dobesilate - a double-blind placebo-controlled multicentre study

By Tejerina T. Ruiz E.

General Pharmacology, Vol. 31, Iss. 3, 1998-09 ,pp. : 357-360

Elsevier

Access to resources Recommend Favorite

Tramadol in the Treatment of Neuropathic Cancer Pain: A Double-Blind, Placebo-Controlled Study

By Arbaiza Daniel Vidal Oscar

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 75-83

Adis International

Access to resources Recommend Favorite

Effect of an Olmesartan Medoxomil-Based Treatment Algorithm on Systolic Blood Pressure in Patients with Stage 1 or 2 Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study

By Kereiakes Dean J.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 239-246

Adis International

Access to resources Recommend Favorite